logo
  Join        Login             Stock Quote

Upcoming Economic Outlook - Report Highlights GlaxoSmithKline plc (ADR) and Bristol Myers Squibb Co.

Friday, June 1, 2012 9:00 AM


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=894186&ProfileId=051205&sourceType=1

HONG KONG -- (Marketwire) -- 06/01/12 -- Today, www.BrightonMarkets.com announced new reports highlighting GlaxoSmithKline plc (ADR) (NYSE: GSK) and Bristol Myers Squibb Co. (NYSE: BMY). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=GSK&cob=BMY.

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on GlaxoSmithKline plc (ADR) for its current position within the healthcare industry. GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The full research report on GlaxoSmithKline plc (ADR) (NYSE: GSK) is available here: www.BrightonMarkets.com/index.php?coa=GSK.

Brighton Markets has released research on Bristol Myers Squibb Co. for its changing role within the healthcare industry. Bristol-Myers Squibb Company (BMS) is a global biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Its products are sold worldwide to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The full research report on Bristol Myers Squibb Co. (NYSE: BMY) is available here: www.BrightonMarkets.com/index.php?cob=BMY.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact:

Jean Barnes
Email Contact
www.BrightonMarkets.com

(Source: Market Wire )
(Source: Quotemedia)

Advertisement
Advertisement



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.